Daiwa Securities Group
ETON icon

Daiwa Securities Group’s Eton Pharmaceutcials ETON Stock Holding History

Daiwa Securities Group’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-89
Closed -$2K – 1269
2025
Q4 		$2K Buy
+89
New +$1.57K ﹤0.01% 1306

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Daiwa Securities Group's ETON Position: Q1 2026 in Review

Daiwa Securities Group sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 89 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in ETON in Q4 2025 and held it in 1 quarter. The position peaked at $2K in Q4 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Daiwa Securities Group reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 89 Eton Pharmaceutcials shares in Q1 2026, an estimated $2K.
  • Daiwa Securities Group first reported a position in Eton Pharmaceutcials in Q4 2025 and held it in 1 quarter.
  • Daiwa Securities Group's Eton Pharmaceutcials position peaked at $2K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.